Im liking these comments by Ms Unwin.
"We are confident that this
work gives the company a model for near term commercial value, and will be validated
when the FPPs are demonstrated to work by delivering a functional cargo in the live
animal (in vivo) models expected to be completed in the first quarter of 2018.”
Personally i am hoping and expecting that we will see some commercial benefits from FPPs way sooner than any myc inhibitors.
Ann: New Delivery Vehicles Show Improved Performance Inside Cells, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
-0.015(1.17%) |
Mkt cap ! $729.0M | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.29 | $1.25 | $4.615M | 3.648M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19881 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.27 | 18943 | 6 |
View Market Depth
| Last trade - 13.50pm 26/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |